Global Psoriatic Arthritis (PsA) Treatments Market Size, Status and Forecast 2022

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 118650


This report studies the global Psoriatic Arthritis (PsA) Treatments market, analyzes and researches the Psoriatic Arthritis (PsA) Treatments development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Celgene Corporation
Amgen Inc
AbbVie
F Hoffmann-La Roche AG
Janssen Global Services
Eli Lilly and Company
UCBInc
Bristol-Myers Squibb Company
Novartis AG

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Psoriatic Arthritis (PsA) Treatments can be split into
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others

Market segment by Application, Psoriatic Arthritis (PsA) Treatments can be split into
Hospitals
Clinics
Other


Table of Contents

Global Psoriatic Arthritis (PsA) Treatments Market Size, Status and Forecast 2022
1 Industry Overview of Psoriatic Arthritis (PsA) Treatments
1.1 Psoriatic Arthritis (PsA) Treatments Market Overview
1.1.1 Psoriatic Arthritis (PsA) Treatments Product Scope
1.1.2 Market Status and Outlook
1.2 Global Psoriatic Arthritis (PsA) Treatments Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Psoriatic Arthritis (PsA) Treatments Market by Type
1.3.1 TNF Inhibitors
1.3.2 PDE4 Inhibitors
1.3.3 Interleukin Blockers
1.3.4 Others
1.4 Psoriatic Arthritis (PsA) Treatments Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other

2 Global Psoriatic Arthritis (PsA) Treatments Competition Analysis by Players
2.1 Psoriatic Arthritis (PsA) Treatments Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Celgene Corporation
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Amgen Inc
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 AbbVie
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 F Hoffmann-La Roche AG
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Janssen Global Services
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Eli Lilly and Company
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 UCBInc
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Bristol-Myers Squibb Company
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Novartis AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Psoriatic Arthritis (PsA) Treatments Revenue (Value) (2012-2017)
3.9.5 Recent Developments

4 Global Psoriatic Arthritis (PsA) Treatments Market Size by Type and Application (2012-2017)
4.1 Global Psoriatic Arthritis (PsA) Treatments Market Size by Type (2012-2017)
4.2 Global Psoriatic Arthritis (PsA) Treatments Market Size by Application (2012-2017)
4.3 Potential Application of Psoriatic Arthritis (PsA) Treatments in Future
4.4 Top Consumer/End Users of Psoriatic Arthritis (PsA) Treatments

5 United States Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
5.1 United States Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
5.2 United States Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

6 EU Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
6.1 EU Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
6.2 EU Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

7 Japan Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
7.1 Japan Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
7.2 Japan Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

8 China Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
8.1 China Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
8.2 China Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

9 India Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
9.1 India Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
9.2 India Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Psoriatic Arthritis (PsA) Treatments Development Status and Outlook
10.1 Southeast Asia Psoriatic Arthritis (PsA) Treatments Market Size (2012-2017)
10.2 Southeast Asia Psoriatic Arthritis (PsA) Treatments Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Psoriatic Arthritis (PsA) Treatments Market Size (Value) by Regions (2017-2022)
11.1.1 United States Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.1.2 EU Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.1.3 Japan Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.1.4 China Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.1.5 India Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Psoriatic Arthritis (PsA) Treatments Revenue and Growth Rate (2017-2022)
11.2 Global Psoriatic Arthritis (PsA) Treatments Market Size (Value) by Type (2017-2022)
11.3 Global Psoriatic Arthritis (PsA) Treatments Market Size by Application (2017-2022)

12 Psoriatic Arthritis (PsA) Treatments Market Dynamics
12.1 Psoriatic Arthritis (PsA) Treatments Market Opportunities
12.2 Psoriatic Arthritis (PsA) Treatments Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Psoriatic Arthritis (PsA) Treatments Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Psoriatic Arthritis (PsA) Treatments Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source